Discontinuation and dose adjustment of metoprolol after metoprolol-paroxetine/fluoxetine co-prescription in Dutch elderly.

about

Discontinuation and dose adjustment of metoprolol after metoprolol-paroxetine/fluoxetine co-prescription in Dutch elderly.

Item

http://www.wikidata.org/entity/Q55396723

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Discontinuation and dose adjus ...... prescription in Dutch elderly.

@en

Discontinuation and dose adjus ...... prescription in Dutch elderly.

@nl

type

Item

label

Discontinuation and dose adjus ...... prescription in Dutch elderly.

@en

Discontinuation and dose adjus ...... prescription in Dutch elderly.

@nl

prefLabel

Discontinuation and dose adjus ...... prescription in Dutch elderly.

@en

Discontinuation and dose adjus ...... prescription in Dutch elderly.

@nl

P1476

Discontinuation and dose adjus ...... -prescription in Dutch elderly

@en

P2093

Bob Wilffert

http://www.w3.org/2001/XMLSchema#string

Eelko Hak

http://www.w3.org/2001/XMLSchema#string

Jens H J Bos

http://www.w3.org/2001/XMLSchema#string

P2860

Fluoxetine: clinical pharmacology and physiologic disposition

Fluoxetine- and norfluoxetine-mediated complex drug-drug interactions: in vitro to in vivo correlation of effects on CYP2D6, CYP2C19, and CYP3A4

Influence of gender and oral contraceptives on CYP2D6 and CYP2C19 activity in healthy volunteers

Bradycardia during citalopram treatment: a case report

Citalopram-induced bradycardia and presyncope.

Effects of liver disease on pharmacokinetics. An update.

Impact of Muscarinic M3 Receptor Antagonism on the Risk of Type 2 Diabetes in Antidepressant-Treated Patients: A Case-Controlled Study.

CYP2D6 status of extensive metabolizers after multiple-dose fluoxetine, fluvoxamine, paroxetine, or sertraline.

CYP2D6 inhibition by fluoxetine, paroxetine, sertraline, and venlafaxine in a crossover study: intraindividual variability and plasma concentration correlations.

Influence of metoprolol dosage release formulation on the pharmacokinetic drug interaction with paroxetine.

P304

621-629

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PDS.4422

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Muh Akbar Bahar

Yuanyuan Wang

P577

2018-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29575226

http://www.w3.org/2001/XMLSchema#string

P932

6001522

http://www.w3.org/2001/XMLSchema#string